Clearside Biomedical to Present at the Ophthalmology Futures European 2021 Virtual Retina Forum
August 23, 2021 16:05 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...
Medical Biomimetics Market Revenue 2021: Top 4 Trends Driving the Industry Expansion Through 2027; Global Market Insights Inc.
August 18, 2021 06:00 ET
|
Global Market Insights, Inc
Selbyville, Delaware, Aug. 18, 2021 (GLOBE NEWSWIRE) -- The medical biomimetics market size is anticipated to record a valuation of USD 53 billion by 2027, according to the most recent study by...
Insights on the Retinal Surgery Devices Global Market to 2026 - Featuring Lumenis, Nidek and Optos Among Others
August 16, 2021 08:33 ET
|
Research and Markets
Dublin, Aug. 16, 2021 (GLOBE NEWSWIRE) -- The "Retinal Surgery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
Clearside Biomedical Announces Second Quarter 2021 Financial Results and Provides Corporate Update
August 10, 2021 16:05 ET
|
Clearside Biomedical, Inc.
- Enrollment Underway in Cohort 2 of OASIS Wet AMD Phase 1/2a Trial with Data Expected by the End of 2021 – - Upcoming FDA PDUFA Action Date in October 2021 for XIPERE™ (triamcinolone acetonide...
Tarsus Pharmaceuticals, Inc. Reports Second Quarter 2021 Financial Results and Provides Business and Clinical Updates
August 04, 2021 17:30 ET
|
Tarsus Pharmaceuticals, Inc
Announced positive results of the Saturn-1 pivotal trial evaluating TP-03 for the treatment of Demodex blepharitis; results presented at the 2021 American Society of Cataract and Refractive Surgery...
Clearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021
August 04, 2021 07:05 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...
Global Corneal Implants Market (2021 to 2026) - Growth, Trends, COVID-19 Impact and Forecasts
August 04, 2021 04:53 ET
|
Research and Markets
Dublin, Aug. 04, 2021 (GLOBE NEWSWIRE) -- The "Corneal Implants Market- Growth, Trends, COVID-19 Impact and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering. The...
Eyenuk AI Technology Selected for Diabetic Eye Testing in Vietnam Supported by The Fred Hollows Foundation
July 26, 2021 09:00 ET
|
Eyenuk, Inc.
LOS ANGELES, July 26, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...
Tarsus Pharmaceuticals, Inc. Presents New Saturn-1 Pivotal Trial Data and Titan Real-World Prevalence Study Results at ASCRS 2021
July 24, 2021 18:00 ET
|
Tarsus Pharmaceuticals, Inc
New Saturn-1 data demonstrated a strong patient responder rate with 95% of Demodex blepharitis patients treated with TP-03 achieving ≤0.5 mites per lash and 93% improving by at least one collarette...
Eyenuk Announces $6.2 Million Financing to Accelerate Adoption of FDA-cleared AI Technology for Detection of Diabetic Retinopathy
July 20, 2021 08:00 ET
|
Eyenuk, Inc.
LOS ANGELES, July 20, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...